156 related articles for article (PubMed ID: 38664791)
1. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of high-risk human papillomavirus infection and cervical lesions among female migrant head porters (kayayei) in Accra, Ghana: a pilot cross-sectional study.
Tekpor E; Effah K; Sifa J; Amuah JE; Essel NOM; Kemawor S; Wormenor CM; Sesenu E; Danyo S; Akakpo PK
BMC Public Health; 2024 Mar; 24(1):659. PubMed ID: 38429784
[TBL] [Abstract][Full Text] [Related]
3. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.
Krings A; Dunyo P; Pesic A; Tetteh S; Hansen B; Gedzah I; Wormenor CM; Amuah JE; Behnke AL; Höfler D; Pawlita M; Kaufmann AM
PLoS One; 2019; 14(6):e0218762. PubMed ID: 31246997
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.
Temesgen MM; Alemu T; Shiferaw B; Legesse S; Zeru T; Haile M; Gelanew T
PLoS One; 2021; 16(3):e0248949. PubMed ID: 33760866
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
[TBL] [Abstract][Full Text] [Related]
9. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
Ali MAM; Bedair RN; Abd El Atti RM
Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35-64 years old women who received cervical cancer screening in Beijing].
Shen J; Gao LL; Zhang Y; Han LL; Wang JD
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):493-497. PubMed ID: 29747341
[No Abstract] [Full Text] [Related]
11. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
12. Associations Between Vaginal Infections and Potential High-risk and High-risk Human Papillomavirus Genotypes in Female Sex Workers in Western Kenya.
Menon S; Broeck DV; Rossi R; Ogbe E; Harmon S; Mabeya H
Clin Ther; 2016 Dec; 38(12):2567-2577. PubMed ID: 27836494
[TBL] [Abstract][Full Text] [Related]
13. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
14. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
[TBL] [Abstract][Full Text] [Related]
16. Tritesting in Battor, Ghana: an integrated cervical precancer screening strategy to mitigate the challenges of multiple screening visits and loss to follow-up.
Effah K; Tekpor E; Wormenor CM; Essel NOM; Kemawor S; Sesenu E; Danyo S; Kitcher YT; Klutsey GB; Tay G; Tibu F; Abankroh KA; Atuguba BH; Akakpo PK
Ecancermedicalscience; 2023; 17():1645. PubMed ID: 38414966
[TBL] [Abstract][Full Text] [Related]
17. Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana.
Dei-Adomakoh Y; Effah K; Tekpor E; Crabbe S; Amuah JE; Wormenor CM; Tay G; Asare EV; Kemawor S; Danyo S; Morkli EAC; Tibu F; Essel NO; Akakpo PK
Ecancermedicalscience; 2023; 17():1571. PubMed ID: 37533951
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of high-risk human papillomavirus infection and associated factors among women of reproductive age attending a rural teaching hospital in western Uganda.
Nang DW; Tukirinawe H; Okello M; Tayebwa B; Theophilus P; Sikakulya FK; Fajardo Y; Afodun AM; Kajabwangu R
BMC Womens Health; 2023 Apr; 23(1):209. PubMed ID: 37118735
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand.
Delory T; Ngo-Giang-Huong N; Rangdaeng S; Chotivanich N; Limtrakul A; Putiyanun C; Suriyachai P; Matanasarawut W; Jarupanich T; Liampongsabuddhi P; Heard I; Jourdain G; Lallemant M; Le Coeur S;
J Infect; 2017 May; 74(5):501-511. PubMed ID: 28254419
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions.
López Diez E; Pérez S; Iñarrea A; de la Orden A; Castro M; Almuster S; Tortolero L; Rodríguez M; Montero R; Ojea A
Enferm Infecc Microbiol Clin; 2017 May; 35(5):273-277. PubMed ID: 27004428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
